查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1423071

2024-2032 年按物种、衍生物（大麻二酚、四氢大麻酚等）、应用、最终用途、给药途径和地区分类的医用大麻市场报告

Medical Cannabis Market Report by Species, Derivatives (Cannabidiol, Tetrahydrocannabinol, and Others), Application, End-Use, Route of Administration, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

2023年全球医用大麻市场规模达344亿美元。展望未来， IMARC Group预计到2032年市场规模将达到667亿美元，2024-2032年复合年增长率（CAGR）为7.4%。治疗物质使用障碍的产品使用不断增加、慢性发炎产品的探索、胃肠道疾病的产品需求不断增长以及基于 CBD 的产品需求不断增长是推动市场的一些因素。

医用大麻，也称为医用大麻，是一种源自大麻或印度大麻种的植物药物。它含有大麻素，包括四氢大麻酚（THC）和大麻二酚（CBD），它们与人体的内源性大麻素系统相互作用产生治疗作用。它在缓解症状和治疗各种医疗状况方面显示出潜力，包括慢性疼痛、癫痫、多发性硬化症和化疗引起的噁心。它的药用用途已在许多国家和州合法化，并受到严格的法规和医疗处方的约束。医用大麻的研究不断增长，探索其治疗各种健康状况的功效。

全球市场的主要动力是该产品在医疗用途上的接受度不断提高。与此一致的是，该产品合法化的扩大对市场做出了重大贡献。此外，人们对该产品潜在治疗功效的认识不断提高，正在对市场产生积极影响。除此之外，大麻研究和医学研究的快速进展为市场提供了许多机会。此外，慢性疼痛和其他可用该产品治疗的疾病的日益流行正在刺激市场。此外，人口老化不断加剧，寻求与年龄相关的疾病的替代疗法正在推动市场发展。阿片类药物危机和对更安全的疼痛管理方案的寻求正在提振市场。此外，对天然和植物药物的需求不断增长也推动了市场的发展。

医用大麻市场趋势/驱动因素：

大麻适应症的临床试验、研发 (R&D) 活动和商业化不断增加

大麻适应症的临床试验、研发（R＆D）活动和商业化的不断增加正在培育市场。随着接受度和合法化程度的提高，研究人员、製药公司和医疗专业人员越来越有兴趣探索该产品的潜在治疗效果。临床试验和研究对于提供支持大麻治疗各种疾病的功效和安全性的科学证据至关重要。随着这些研究出现更多积极的结果，人们对医用大麻作为合法治疗选择的信心增加，从而导致更广泛的采用。此外，製药公司和新创公司对大麻适应症的商业化进行了大量投资。标准化大麻药品的开发提供了更一致的剂量、品质控制和监管合规性，进一步使该产品在医疗保健行业的合法化。随着该产品更加牢固地融入主流医学，市场预计将扩大，吸引更多的患者、医疗保健提供者和投资者。研究、开发和商业化的积极势头推动了市场的发展。

消费者可支配所得膨胀

消费者可支配所得的膨胀对市场产生了有利的影响。随着可支配收入的增加，消费者有更多的经济能力用于医疗保健，包括替代和补充治疗。随着购买力的增强，个人更有可能探索和投资针对各种健康状况的产品。医用大麻在某些地区可能不受保险覆盖，但对于可支配收入较高的消费者来说，可以成为可行的选择。可支配所得的膨胀也导致消费者偏好转向更全面、更自然的健康疗法。随着人们优先考虑自己的福祉，他们寻求传统药物以外的替代治疗方法，从而导致对该产品的需求增加。此外，更高的可支配收入使消费者能够负担得起这些更高品质或来源可靠的产品，从而推动了高端市场的发展。

新的大麻医学产品的出现

新的大麻医药产品的出现正在提振市场。随着研究和临床试验继续探索大麻素和其他大麻衍生化合物的治疗潜力，製药公司正在开发以大麻为基础的创新药物。这些新药品经过严格的测试和监管批准，让医疗专业人员和患者对其安全性和有效性充满信心。因此，更多的医疗保健提供者愿意为各种医疗状况开出基于大麻的药物，从而推动市场采用。标准化大麻药物的开发也解决了对剂量一致性和品质控制的担忧，使它们对患者和医疗保健提供者更加可靠和有吸引力。此外，新型大麻药物的出现扩大了医用大麻在治疗从慢性疼痛、神经系统疾病到精神健康疾病等多种疾病的潜在应用。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球医用大麻市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场区隔：依品种
  • 市场区隔：依衍生性商品分类
  • 市场区隔：按应用
  • 市场区隔：最终用途别
  • 市场区隔：依给药途径
  • 市场区隔：按地区
  • 市场预测
  • SWOT分析
    • 概述
    • 优势
    • 弱点
    • 机会
    • 威胁
  • 价值链分析
    • 输入供应商
    • 收藏家
    • 製造商
    • 经销商
    • 出口商
    • 零售商
    • 最终用户
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁
  • 关键成功因素与风险因素

第 6 章：市场区隔：依品种

  • 籼稻
    • 市场走向
    • 市场预测
  • 苜蓿
    • 市场走向
    • 市场预测
  • 杂交种
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依衍生性商品分类

  • 大麻二酚 (CBD)
    • 市场走向
    • 市场预测
  • 四氢大麻酚 (THC)
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按应用

  • 癌症
    • 市场走向
    • 市场预测
  • 关节炎
    • 市场走向
    • 市场预测
  • 偏头痛
    • 市场走向
    • 市场预测
  • 癫痫
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：最终用途别

  • 医药行业
    • 市场走向
    • 市场预测
  • 研发中心
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：市场区隔：依管理途径

  • 口服溶液和胶囊
    • 市场走向
    • 市场预测
  • 汽化器
    • 市场走向
    • 市场预测
  • 专题
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 11 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 荷兰
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 市场走向
    • 市场预测
  • 亚太地区
    • 市场走向
    • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场预测

第 12 章：临床研究概述显示医用大麻对各种适应症的益处

  • 阿兹海默氏症
  • 自闭症
  • 癌症
  • 慢性疼痛
  • 癫痫
  • 偏头痛
  • 消化系统疾病
  • 多发性硬化症
  • 精神分裂症
  • 其他的

第13章：竞争格局

  • 市场结构
  • 关键参与者

第 14 章：关键球员简介

  • Canopy Growth Corporation
  • GW Pharmaceuticals, plc
  • Aurora Cannabis, Inc.
  • Aphria, Inc.
  • MedReleaf Corporation
  • Insys Therapeutics, Inc.
  • CanniMed Therapeutics, Inc.
  • Cara Therapeutics, Inc.
  • United Cannabis Corporation
Product Code: SR112024A1053

Abstract

The global medical cannabis market size reached US$ 34.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 66.7 Billion by 2032, exhibiting a growth rate (CAGR) of 7.4% during 2024-2032. The increasing product use in treating substance use disorders, the exploration of products for chronic inflammatory conditions, the rising product demand for gastrointestinal disorders, and the rising demand for CBD-based products are some of the factors propelling the market.

Medical cannabis, also known as medical marijuana, is a plant-based medicine derived from the Cannabis sativa or Cannabis indica species. It contains cannabinoids, including tetrahydrocannabinol (THC) and cannabidiol (CBD), which interact with the body's endocannabinoid system to produce therapeutic effects. It has shown potential in alleviating symptoms and managing various medical conditions, including chronic pain, epilepsy, multiple sclerosis, and nausea caused by chemotherapy. Its medicinal use has been legalized in many countries and states, subject to strict regulations and medical prescriptions. Research on medical cannabis continues to grow, exploring its efficacy in treating various health conditions.

The global market is majorly driven by the increasing acceptance of the product for medicinal purposes. In line with this, the expanding legalization of the product is significantly contributing to the market. Furthermore, the rising awareness of the potential therapeutic benefits of the product is positively influencing the market. Apart from this, the rapid advancements in cannabis research and medical studies are offering numerous opportunities for the market. Moreover, the growing prevalence of chronic pain and other medical conditions treatable with the product is catalyzing the market. Besides, the escalating aging population seeking alternative treatments for age-related ailments is propelling the market. The opioid crisis and the search for safer pain management options are bolstering the market. Additionally, the increasing demand for natural and plant-based medicines is providing a boost to the market.

Medical Cannabis Market Trends/Drivers:

Rising clinical trials, research and development (R&D) activities, and commercialization of cannabis-based indications

The rising clinical trials, research and development (R&D) activities, and commercialization of cannabis-based indications are fostering the market. With increasing acceptance and legalization, there is a growing interest among researchers, pharmaceutical companies, and medical professionals to explore the potential therapeutic benefits of the product. Clinical trials and research studies are essential to provide scientific evidence supporting the efficacy and safety of cannabis-based treatments for various medical conditions. As more positive results emerge from these studies, confidence in medical cannabis as a legitimate treatment options increases, leading to wider adoption. Furthermore, commercializing cannabis-based indications has seen substantial investments from pharmaceutical companies and startups. The development of standardized cannabis-based pharmaceutical products offers more consistent dosing, quality control, and regulatory compliance, further legitimizing the product in the healthcare industry. As the product becomes more firmly integrated into mainstream medicine, the market is expected to expand, attracting more patients, healthcare providers, and investors. This positive momentum in research, development, and commercialization fuels the market.

Inflating disposable incomes of the consumers

The inflating disposable incomes of the consumers are favorably impacting the market. As disposable incomes rise, consumers have more financial capacity to spend on healthcare, including alternative and complementary treatments. With increased purchasing power, individuals are more likely to explore and invest in the product for various health conditions. Medical cannabis, which may not be covered by insurance in some regions, can become a viable option for consumers with higher disposable incomes. Inflating disposable incomes also contribute to a shift in consumer preferences towards more holistic and natural health remedies. As individuals prioritize their well-being, they seek alternative treatments beyond traditional pharmaceuticals, leading to increased demand for the product. Additionally, higher disposable incomes allow consumers to afford these products that may be of higher quality or from reputable sources, boosting the premium segment of the market.

The emergence of new cannabis-based pharmaceutical products

The emergence of new cannabis-based pharmaceutical products is bolstering the market. As research and clinical trials continue to explore the therapeutic potential of cannabinoids and other cannabis-derived compounds, pharmaceutical companies are developing innovative cannabis-based medications. These new pharmaceutical products undergo rigorous testing and regulatory approvals, instilling confidence in medical professionals and patients about their safety and efficacy. As a result, more healthcare providers are open to prescribing cannabis-based medications for various medical conditions, thus driving market adoption. The development of standardized cannabis-based pharmaceuticals also addresses concerns about dosage consistency and quality control, making them more reliable and appealing to patients and healthcare providers. Moreover, the emergence of new cannabis-based medications expands the potential applications of medical cannabis in treating a wide range of conditions, from chronic pain and neurological disorders to mental health ailments.

Medical Cannabis Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global medical cannabis market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on species, derivatives, application, end-use and route of administration.

Breakup by Species:

Indica

Sativa

Hybrid

Indica dominates the market

The report has provided a detailed breakup and analysis of the market based on the species. This includes indica, sativa, and hybrid. According to the report, indica represented the largest segment.

As one of the primary cannabis species, Cannabis indica is known for its high CBD content and relatively lower THC levels compared to Cannabis sativa. The increased interest in CBD-based products and therapeutic applications has boosted the demand for Cannabis indica strains. CBD is recognized for its potential benefits in managing various health conditions, such as pain, anxiety, and inflammation, without inducing the psychoactive effects commonly associated with THC.

Moreover, Indica's relaxing and sedative properties make it appealing for medicinal use in addressing sleep disorders and promoting relaxation. As consumers seek natural alternatives to traditional medications, Cannabis indica is increasingly sought after as a potential treatment option. The evolving legal landscape and greater acceptance of medical cannabis have also contributed to the market growth of Cannabis indica products. With the increasing number of states and countries legalizing medical cannabis, indica strains are gaining traction among patients and healthcare professionals, propelling market expansion further.

Breakup by Derivatives:

Cannabidiol (CBD)

Tetrahydrocannabinol (THC)

Others

Tetrahydrocannabinol (THC) dominates the market

The report has provided a detailed breakup and analysis of the market based on the derivatives. This includes cannabidiol (CBD), tetrahydrocannabinol (THC), and others. According to the report, THC represented the largest segment.

Tetrahydrocannabinol (THC) is crucial in propelling the market due to its psychoactive properties and potential therapeutic benefits. As one of the primary cannabinoids found in cannabis, THC is known for its ability to interact with the body's endocannabinoid system, producing various physiological and psychological effects. The psychoactive nature of THC attracts a segment of consumers seeking relief from pain, stress, and anxiety, making it an appealing option for medicinal use. Patients with chronic pain, cancer-related symptoms, and multiple sclerosis may find THC-containing medical cannabis products beneficial in managing their symptoms.

Furthermore, the recreational use of THC has helped destigmatize cannabis overall, leading to increased acceptance and legalization of medical cannabis in various regions. This evolving legal landscape has contributed to the market growth of medical cannabis, making it more accessible to patients in need. As research continues to explore the potential medical applications of THC and its combination with other cannabinoids, the demand for products containing THC is expected to grow, further driving the market expansion.

Breakup by Application:

Cancer

Arthritis

Migraine

Epilepsy

Others

Cancer dominates the market

The report has provided a detailed breakup and analysis of the market based on the application. This includes cancer, arthritis, migraine, epilepsy, and others. According to the report, cancer represented the largest segment.

Cancer is a significant market driver due to its potential to manage cancer-related symptoms and side effects of cancer treatments. Medical cannabis has shown promise in alleviating chemotherapy-induced nausea and vomiting and stimulating appetite in cancer patients experiencing cachexia and weight loss. Moreover, cancer-related pain management is critical for medical cannabis usage, as cannabinoids, including THC and CBD, may offer analgesic properties. Patients seeking alternatives to traditional pain medications are turning to medical cannabis to manage pain and improve their quality of life.

Furthermore, medical cannabis may have anti-inflammatory and anti-tumor properties, sparking interest in its potential role as an adjunct therapy in cancer treatment. Research continues to explore these possibilities, driving the demand for medical cannabis products. The growing number of cancer patients and increasing acceptance of medical cannabis as a complementary treatment option contributes to market growth. As medical professionals recognize the potential benefits, cancer patients are increasingly incorporating medical cannabis into their treatment plans, further fueling the market.

Breakup by End-Use:

Pharmaceutical Industry

Research and Development Centres

Others

Pharmaceutical industry dominates the market

The report has provided a detailed breakup and analysis of the market based on the end-use. This includes the pharmaceutical industry, research and development centres, and others. According to the report, the pharmaceutical industry represented the largest segment.

The pharmaceutical industry is pivotal in strengthening the market through extensive research and development, and commercialization of cannabis-based medications. As the potential therapeutic benefits of cannabinoids and cannabis-derived compounds gain recognition, pharmaceutical companies are investing in clinical trials and R&D activities to develop novel cannabis-based pharmaceutical products. These companies are exploring various delivery methods, formulations, and dosages to create standardized and regulated medical cannabis treatments. By developing pharmaceutical-grade cannabis products, they aim to address concerns about consistency, safety, and efficacy, which are essential for medical professionals and patients.

Furthermore, pharmaceutical companies' involvement in the medical cannabis market brings credibility and legitimacy to the industry, encouraging wider acceptance and adoption by healthcare professionals. This collaboration between the pharmaceutical industry and medical cannabis fosters the integration of cannabis-based treatments into mainstream medicine, driving market growth and expanding the scope of medical cannabis usage for various health conditions.

Breakup by Route of Administration:

Oral Solutions and Capsules

Vaporizers

Topicals

Others

Oral solutions and capsules dominate the market

The report has provided a detailed breakup and analysis of the market based on the route of administration. This includes oral solutions and capsules, vaporizers, topicals and others. According to the report, oral solutions and capsules represented the largest segment.

Oral solutions and capsules are propelling the market due to their convenience, dosage accuracy, and ease of administration. As pharmaceutical companies develop standardized cannabis-based medications in these forms, patients can consume medical cannabis more discreetly and precisely. Oral solutions and capsules offer consistent dosing, making it easier for healthcare professionals to prescribe and monitor patient treatment. This standardization fosters confidence in medical cannabis as a legitimate therapeutic option.

Moreover, these delivery methods cater to patients who prefer a smoke-free and non-inhalation approach to medical cannabis consumption. They especially appeal to older adults and individuals seeking alternative treatments for various health conditions. The convenience of oral solutions and capsules contributes to better patient compliance, leading to more successful treatment outcomes. As medical cannabis gains wider acceptance and pharmaceutical-grade products become available in these forms, the market growth of medical cannabis is accelerated, attracting patients and healthcare professionals to explore its therapeutic potential further.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

Europe

Germany

France

Italy

Spain

Netherlands

Latin America

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest medical cannabis market share

The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada); Asia Pacific, Europe (Germany, Italy, France, the Netherlands, and Spain), Latin America, and Middle East and Africa. According to the report, North America accounted for the largest market share.

North America is fostering the market growth due to its progressive regulatory environment, increasing acceptance, and widespread legalization across various states and countries in the region. In particular, the United States and Canada have been at the forefront of the medical cannabis movement, with many states and provinces legalizing medical cannabis for therapeutic use. The growing awareness and acceptance of medical cannabis have increased patient demand as individuals seek alternative treatments for various medical conditions. This increasing demand, in turn, has spurred investments in research, development, and commercialization of medical cannabis products, driving market growth.

Moreover, well-established pharmaceutical companies and research institutions in North America have accelerated the development of standardized and regulated cannabis-based medications, further propelling market expansion. The evolving legal landscape, coupled with a strong consumer base and supportive healthcare policies, positions North America as a significant driving force behind the market's global growth.

Competitive Landscape:

Top companies are strengthening the market by leveraging their resources, expertise, and brand recognition. These companies invest heavily in research and development to create innovative cannabis-based products with consistent quality and efficacy. They expand their presence in key markets through strategic partnerships and acquisitions, driving consumer awareness and accessibility. Their established distribution networks enable the widespread availability of medical cannabis products, reaching a broader patient base. Furthermore, these companies also engage in educational initiatives to raise awareness among healthcare professionals and the general public about the therapeutic potential of medical cannabis. Their efforts to comply with regulatory standards and maintain product safety build trust and credibility in the industry. By setting high industry standards and fostering best practices, these companies contribute to the market growth, leading the way for continued expansion and acceptance of medical cannabis as a legitimate and effective treatment option.

The report has provided a comprehensive analysis of the competitive landscape in the medical cannabis market. Detailed profiles of all major companies have also been provided.

Canopy Growth Corporation

GW Pharmaceuticals, plc

Aurora Cannabis, Inc.

Aphria, Inc.

MedReleaf Corporation

Insys Therapeutics, Inc.

CanniMed Therapeutics, Inc.

Cara Therapeutics, Inc.

United Cannabis Corporation

Recent Developments:

In 2020, Canopy Growth entered a strategic partnership with Acreage Holdings, Inc., a U.S.-based cannabis operator. This agreement was structured to allow Canopy Growth to acquire Acreage once cannabis becomes federally legal in the United States. This collaboration aimed to position Canopy Growth for future growth in the U.S. cannabis market.

In 2021, GW Pharmaceuticals was acquired by Jazz Pharmaceuticals. This acquisition allowed Jazz Pharmaceuticals to expand its product portfolio into the cannabinoid-based therapies domain and bolster its presence in the neurology and rare disease markets.

In 2021, Aurora Cannabis completed a strategic business transformation plan involving various cost-saving initiatives, restructuring, and divestitures to improve financial performance and focus on its core businesses.

Key Questions Answered in This Report

  • 1. What was the size of the global medical cannabis market in 2023?
  • 2. What is the expected growth rate of the global medical cannabis market during 2024-2032?
  • 3. What are the key factors driving the global medical cannabis market?
  • 4. What has been the impact of COVID-19 on the global medical cannabis market?
  • 5. What is the breakup of the global medical cannabis market based on the species?
  • 6. What is the breakup of the global medical cannabis market based on the derivatives?
  • 7. What is the breakup of the global medical cannabis market based on the application?
  • 8. What is the breakup of the global medical cannabis market based on end-use?
  • 9. What is the breakup of the global medical cannabis market based on the route of administration?
  • 10. What are the key regions in the global medical cannabis market?
  • 11. Who are the key players/companies in the global medical cannabis market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Medical Cannabis Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Species
  • 5.5 Market Breakup by Derivatives
  • 5.6 Market Breakup by Application
  • 5.7 Market Breakup by End-Use
  • 5.8 Market Breakup by Route of Administration
  • 5.9 Market Breakup by Region
  • 5.10 Market Forecast
  • 5.11 SWOT Analysis
    • 5.11.1 Overview
    • 5.11.2 Strengths
    • 5.11.3 Weaknesses
    • 5.11.4 Opportunities
    • 5.11.5 Threats
  • 5.12 Value Chain Analysis
    • 5.12.1 Input Suppliers
    • 5.12.2 Collectors
    • 5.12.3 Manufacturers
    • 5.12.4 Distributors
    • 5.12.5 Exporters
    • 5.12.6 Retailers
    • 5.12.7 End-User
  • 5.13 Porters Five Forces Analysis
    • 5.13.1 Overview
    • 5.13.2 Bargaining Power of Buyers
    • 5.13.3 Bargaining Power of Suppliers
    • 5.13.4 Degree of Competition
    • 5.13.5 Threat of New Entrants
    • 5.13.6 Threat of Substitutes
  • 5.14 Key Success and Risk Factors

6 Market Breakup by Species

  • 6.1 Indica
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Sativa
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Hybrid
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Derivatives

  • 7.1 Cannabidiol (CBD)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Tetrahydrocannabinol (THC)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Cancer
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Arthritis
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Migraine
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Epilepsy
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End-Use

  • 9.1 Pharmaceutical Industry
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Research and Development Centres
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Route of Administration

  • 10.1 Oral Solutions and Capsules
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Vaporizers
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Topicals
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Europe
    • 11.2.1 Germany
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Italy
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 France
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 Netherlands
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Spain
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
  • 11.3 Latin America
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast
  • 11.4 Asia Pacific
    • 11.4.1 Market Trends
    • 11.4.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Forecast

12 Overview of Clinical Research Suggesting the Benefits of Medical Cannabis Across Various Indications

  • 12.1 Alzheimer's Disease
  • 12.2 Autism
  • 12.3 Cancer
  • 12.4 Chronic Pain
  • 12.5 Epilepsy
  • 12.6 Migraine
  • 12.7 Digestive Disorders
  • 12.8 Multiple Sclerosis
  • 12.9 Schizophrenia
  • 12.10 Others

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players

14 Key Player Profiles

  • 14.1 Canopy Growth Corporation
  • 14.2 GW Pharmaceuticals, plc
  • 14.3 Aurora Cannabis, Inc.
  • 14.4 Aphria, Inc.
  • 14.5 MedReleaf Corporation
  • 14.6 Insys Therapeutics, Inc.
  • 14.7 CanniMed Therapeutics, Inc.
  • 14.8 Cara Therapeutics, Inc.
  • 14.9 United Cannabis Corporation

List of Figures

  • Figure 1: Global: Medical Cannabis Market: Major Drivers and Challenges
  • Figure 2: Global: Medical Cannabis Market: Value Trends (in Billion US$), 2018-2023
  • Figure 3: Global: Medical Cannabis Market: Breakup by Species (in %), 2023
  • Figure 4: Global: Medical Cannabis Market: Breakup by Derivatives (in %), 2023
  • Figure 5: Global: Medical Cannabis Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Medical Cannabis Market: Breakup by End-Use (in %), 2023
  • Figure 7: Global: Medical Cannabis Market: Breakup by Route of Administration (in %), 2023
  • Figure 8: Global: Medical Cannabis Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Medical Cannabis Market Forecast: Value Trends (in Billion US$), 2024-2032
  • Figure 10: Global: Medical Cannabis Industry: SWOT Analysis
  • Figure 11: Global: Medical Cannabis Industry: Value Chain Analysis
  • Figure 12: Global: Medical Cannabis Industry: Porter's Five Forces Analysis
  • Figure 13: Global: Medical Cannabis Market (Indica): Value Trends (in Million US$), 2018 & 2023
  • Figure 14: Global: Medical Cannabis Market Forecast (Indica): Value Trends (in Million US$), 2024-2032
  • Figure 15: Global: Medical Cannabis Market (Sativa): Value Trends (in Million US$), 2018 & 2023
  • Figure 16: Global: Medical Cannabis Market Forecast (Sativa): Value Trends (in Million US$), 2024-2032
  • Figure 17: Global: Medical Cannabis Market (Hybrid): Value Trends (in Million US$), 2018 & 2023
  • Figure 18: Global: Medical Cannabis Market Forecast (Hybrid): Value Trends (in Million US$), 2024-2032
  • Figure 19: Global: Medical Cannabis Market (Cannabidiol-CBD): Value Trends (in Million US$), 2018 & 2023
  • Figure 20: Global: Medical Cannabis Market Forecast (Cannabidiol-CBD): Value Trends (in Million US$), 2024-2032
  • Figure 21: Global: Medical Cannabis Market (Tetrahydrocannabinol-THC): Value Trends (in Million US$), 2018 & 2023
  • Figure 22: Global: Medical Cannabis Market Forecast (Tetrahydrocannabinol-THC): Value Trends (in Million US$), 2024-2032
  • Figure 23: Global: Medical Cannabis Market (Other Derivatives): Value Trends (in Million US$), 2018 & 2023
  • Figure 24: Global: Medical Cannabis Market Forecast (Other Derivatives): Value Trends (in Million US$), 2024-2032
  • Figure 25: Global: Medical Cannabis Market (Application in Cancer): Value Trends (in Million US$), 2018 & 2023
  • Figure 26: Global: Medical Cannabis Market Forecast (Application in Cancer): Value Trends (in Million US$), 2024-2032
  • Figure 27: Global: Medical Cannabis Market (Application in Arthritis): Value Trends (in Million US$), 2018 & 2023
  • Figure 28: Global: Medical Cannabis Market Forecast (Application in Arthritis): Value Trends (in Million US$), 2024-2032
  • Figure 29: Global: Medical Cannabis Market (Application in Migraine): Value Trends (in Million US$), 2018 & 2023
  • Figure 30: Global: Medical Cannabis Market Forecast (Application in Migraine): Value Trends (in Million US$), 2024-2032
  • Figure 31: Global: Medical Cannabis Market (Application in Epilepsy): Value Trends (in Million US$), 2018 & 2023
  • Figure 32: Global: Medical Cannabis Market Forecast (Application in Epilepsy): Value Trends (in Million US$), 2024-2032
  • Figure 33: Global: Medical Cannabis Market (Other Applications): Value Trends (in Million US$), 2018 & 2023
  • Figure 34: Global: Medical Cannabis Market Forecast (Other Applications): Value Trends (in Million US$), 2024-2032
  • Figure 35: Global: Medical Cannabis Market (End-Use in Pharmaceutical Industry): Value Trends (in Million US$), 2018 & 2023
  • Figure 36: Global: Medical Cannabis Market Forecast (End-Use in Pharmaceutical Industry): Value Trends (in Million US$), 2024-2032
  • Figure 37: Global: Medical Cannabis Market (End-Use in Research and Development Centres): Value Trends (in Million US$), 2018 & 2023
  • Figure 38: Global: Medical Cannabis Market Forecast (End-Use in Research and Development Centres): Value Trends (in Million US$), 2024-2032
  • Figure 39: Global: Medical Cannabis Market (Other End-Uses): Value Trends (in Million US$), 2018 & 2023
  • Figure 40: Global: Medical Cannabis Market Forecast (Other End-Uses): Value Trends (in Million US$), 2024-2032
  • Figure 41: Global: Medical Cannabis Market (Administration through Oral Solutions and Capsules): Value Trends (in Million US$), 2018 & 2023
  • Figure 42: Global: Medical Cannabis Market Forecast (Administration through Oral Solutions and Capsules): Value Trends (in Million US$), 2024-2032
  • Figure 43: Global: Medical Cannabis Market (Administration through Vaporizers): Value Trends (in Million US$), 2018 & 2023
  • Figure 44: Global: Medical Cannabis Market Forecast (Administration through Vaporizers): Value Trends (in Million US$), 2024-2032
  • Figure 45: Global: Medical Cannabis Market (Administration through Topicals): Value Trends (in Million US$), 2018 & 2023
  • Figure 46: Global: Medical Cannabis Market Forecast (Administration through Topicals): Value Trends (in Million US$), 2024-2032
  • Figure 47: Global: Medical Cannabis Market (Other Route of Administrations): Value Trends (in Million US$), 2018 & 2023
  • Figure 48: Global: Medical Cannabis Market Forecast (Other Route of Administrations): Value Trends (in Million US$), 2024-2032
  • Figure 49: North America: Medical Cannabis Market: Value Trends (in Million US$), 2018 & 2023
  • Figure 50: North America: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2024-2032
  • Figure 51: United States: Medical Cannabis Market: Value Trends (in Million US$), 2018 & 2023
  • Figure 52: United States: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2024-2032
  • Figure 53: Canada: Medical Cannabis Market: Value Trends (in Million US$), 2018 & 2023
  • Figure 54: Canada: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2024-2032
  • Figure 55: Europe: Medical Cannabis Market: Value Trends (in Million US$), 2018 & 2023
  • Figure 56: Europe: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2024-2032
  • Figure 57: Germany: Medical Cannabis Market: Value Trends (in Million US$), 2018 & 2023
  • Figure 58: Germany: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2024-2032
  • Figure 59: Italy: Medical Cannabis Market: Value Trends (in Million US$), 2018 & 2023
  • Figure 60: Italy: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2024-2032
  • Figure 61: France: Medical Cannabis Market: Value Trends (in Million US$), 2018 & 2023
  • Figure 62: France: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2024-2032
  • Figure 63: Netherlands: Medical Cannabis Market: Value Trends (in Million US$), 2018 & 2023
  • Figure 64: Netherlands: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2024-2032
  • Figure 65: Spain: Medical Cannabis Market: Value Trends (in Million US$), 2018 & 2023
  • Figure 66: Spain: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2024-2032
  • Figure 67: Latin America: Medical Cannabis Market: Value Trends (in Million US$), 2018 & 2023
  • Figure 68: Latin America: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2024-2032
  • Figure 69: Asia Pacific: Medical Cannabis Market: Value Trends (in Million US$), 2018 & 2023
  • Figure 70: Asia Pacific: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2024-2032
  • Figure 71: Middle East and Africa: Medical Cannabis Market: Value Trends (in Million US$), 2018 & 2023
  • Figure 72: Middle East and Africa: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2024-2032

List of Tables

  • Table 1: Global: Medical Cannabis Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Medical Cannabis Market Forecast: Breakup by Species (in Million US$), 2024-2032
  • Table 3: Global: Medical Cannabis Market Forecast: Breakup by Derivatives (in Million US$), 2024-2032
  • Table 4: Global: Medical Cannabis Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Medical Cannabis Market Forecast: Breakup by End-Use (in Million US$), 2024-2032
  • Table 6: Global: Medical Cannabis Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 7: Global: Medical Cannabis Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Medical Cannabis Market: Competitive Structure
  • Table 9: Global: Medical Cannabis Market: Key Players